Request for Information - Radiopharmaceuticals for Naval Medical Center Portsmouth, VA, Naval Medical Center Camp Lejeune, NC, and Naval Health Clinic Jacksonville, FL
Closed Pre-Solicitation Posted
- Solicitation number
- 12373489
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Portsmouth, Virginia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency is seeking to identify potential sources for radiopharmaceutical supplies and related services to support three Naval Medical Treatment Facilities: Naval Medical Center Portsmouth (Virginia), Naval Medical Center Camp Lejeune (North Carolina), and Naval Health Clinic Jacksonville (Florida). This Request for Information (RFI) is issued solely for market research purposes and does not constitute a formal solicitation; responses will not be accepted as binding offers and will not be returned to respondents. The procurement requires an Indefinite Delivery, Indefinite Quantity contract for unit dose radiopharmaceuticals and associated materials to be delivered on an as-needed basis to each facility's Radiology Department, with a contract effective date of October 1, 2026, replacing expiring contracts. Key requirements include strict on-time delivery performance (95% rate minimum), scheduled deliveries by 7:00 a.m. Monday through Friday, accommodation of same-day emergent orders with two-hour delivery windows, compliance with National Regulatory Commission and Department of Transportation regulations for radioactive materials, and adherence to the Navy Radioactive Materials Permit. The RFI response deadline is April 26, 2026, and potential offerors are responsible for monitoring the Federal Procurement Data System for the release of any formal solicitation.
No set-aside designations have been applied to this procurement, and no incumbent contractor information is disclosed in the pre-solicitation notice. The contract falls under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals), indicating the government is seeking commercial radiopharmaceutical suppliers capable of meeting healthcare facility standards. While specific award values or quantity projections are not provided in the RFI, the scope encompasses three separate medical treatment facilities with varying radiopharmaceutical demands, suggesting a multi-location, ongoing supply commitment. The contractor must maintain responsibility for all personnel, equipment, supplies, facilities, transportation, and supervision necessary to deliver radiopharmaceuticals in compliance with manufacturer specifications, particularly for specialized preparations such as 99mTc eluate and NAI-131 orders. Prospective offerors should note that the government will not accept phone calls regarding this RFI and that current contract expiration is September 30, 2026, establishing the transition timeline for the new contract award.
Notice text
This is a Request for Information (RFI) to identify potential sources possessing the capabilities described herein and ascertain whether the required supplies are commercial in nature. This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offer will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. In keeping with the standards of FAR Part 10, the Government may request additional information from responders. Responders are solely responsible for all expenses associated with responding to this RFI or any follow-up information request. All information received in response to this RFI or any follow-up information request that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future request for proposal will not be entertained.
NOTE: Currently no solicitation exists. Therefore, please do not request a copy of the solicitation. NO PHONE CALLS WILL BE ACCEPTED. It is the responsibility of any potential Offeror to monitor this site for the release of any solicitation.
- RFI Title: Radiopharmaceuticals for the Defense Health Agency (DHA) Multiple Medical Treatment Facilities (MTF).
- LOCATIONS: Naval Medical Center Portsmouth, Portsmouth, VA 23708, Naval Medical Center Camp Lejeune, Jacksonville, NC and Naval Health Clinic Jacksonville, FL.
- BACKGROUND: Three (3) Medical Treatment Facility (MTF) Radiology Departments require one new Indefinite Delivery, Indefinite Quantity contract for the delivery of radiopharmaceuticals, as current contracts expire on September 30, 2026. The radiopharmaceuticals need to be delivered on an as needed basis to each requiring Radiology Department.
- DESCRIPTION: NAICS 325412 Pharmaceutical Preparation Manufacturing, PSC 6505 Drugs and Biologicals. See DRAFT Statement of Work (SOW).
RFI SUBMISSION INSTRUCTIONS:
Responses to the RFI shall adhere to the following formatting and outline instructions:
- All submissions shall be made electronically and be in one of the following formats: Microsoft Word or Adobe PDF.
- Cover Page (1 page)
- Title
- Organization
- Responder’s technical and administrative points of contact (names, addresses, phone numbers and email addresses).
- CAGE Code
3. Capabilities statement SHALL address the following:
- Contractor’s clear understanding and ability to perform the scope of this requirement as detailed in the DRAFT SOW.
- Contractor’s experience performing the same or similar work as detailed in the DRAFT SOW.
- Existing contract vehicles (e.g., GSA schedule) under which the responder currently offers these services, if any.
- Whether the responder provides the required services to the general public under terms and conditions similar to those offered to the Federal Government.
RESPONSES DUE: Sunday, April 26, 2026 by 5 pm EST
SUBMISSION TO: Ms. Carol Uebelacker, carol.e.uebelacker.civ@health.mil
Files
| File | Type | Posted |
|---|---|---|
| Radiopharmaceutical SOW_DRAFT.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity